5 Amino 1MQ: Research, Purity Testing and COA

5 Amino 1MQ isn't a peptide. It's a methylated quinolinium salt: no amino acids, no peptide bonds, and a cation weighing roughly 159 g/mol. Yet a large share of the catalogs listing it file it under peptides anyway, which tells you something useful about how carefully the rest of that listing was checked.

Our team reviews incoming third-party test reports constantly, and the pattern never changes. The purity percentage printed at the top of a certificate of analysis is usually the least informative number on the page.

What is 5 amino 1mq?

5 Amino 1MQ (5-amino-1-methylquinolinium) is a membrane-permeable small-molecule inhibitor of nicotinamide N-methyltransferase, or NNMT, the enzyme that methylates nicotinamide and diverts it away from the NAD+ salvage pathway. It is a research-use-only compound with no published human clinical trials. Any batch should be verified against a lot-matched certificate of analysis before laboratory use.

The common oversimplification is that a high purity figure settles the quality question. It doesn't. An HPLC report can read 99.2% while confirming nothing about whether the material in the vial is actually 5-amino-1-methylquinolinium, because purity and identity are measured on different instruments. What follows covers the NNMT mechanism in detail, the current state of 5-amino-1mq research including the human trial gap, and how to read a 5-amino-1mq certificate of analysis line by line.

How NNMT inhibition rearranges methyl and NAD+ traffic

NNMT does one job. It transfers a methyl group from SAM (S-adenosylmethionine, the cell's universal methyl donor) onto nicotinamide, producing 1-methylnicotinamide (1-MNA) and SAH (S-adenosylhomocysteine). That single reaction carries two downstream consequences, and 5 Amino 1MQ is studied because it interrupts both.

First, nicotinamide is the substrate of the NAD+ salvage pathway, the recycling route that regenerates nicotinamide adenine dinucleotide, the coenzyme that redox reactions and sirtuin enzymes depend on. Once nicotinamide is methylated, it's committed to excretion rather than salvage. Second, every methyl transfer consumes SAM and generates SAH, so sustained NNMT activity depresses the SAM:SAH ratio that governs methylation capacity across the cell. Research has reported elevated NNMT expression in white adipose tissue and liver in metabolic disease models, which is precisely why the enzyme became a target.

What separated this compound from earlier NNMT inhibitors is permeability. Bisubstrate analogs assembled from SAM and nicotinamide fragments inhibited the isolated enzyme well, but were too large and too polar to cross a cell membrane, so they collapsed the moment anyone moved from a cuvette to intact cells. 5 Amino 1MQ is small, permanently cationic and membrane-permeable, which is why it sits among oral research compounds rather than injectable material.

In our experience fielding questions about this compound, the mechanism gets explained ten times more often than the sourcing does. Sourcing is where experiments actually fail.

What the published research shows, and where the evidence stops

The 5-amino-1mq research base is preclinical. Published work on membrane-permeable NNMT inhibitors, including research led by Neelakantan and colleagues in Biochemical Pharmacology, reported that administering this inhibitor class to diet-induced obese mice reduced body weight and adipose tissue mass without a matching drop in food intake, alongside reduced NNMT activity in fat tissue. Cell-based work has examined the same enzyme in adipocytes, hepatocytes and several cancer lines where NNMT is overexpressed.

Now the part most pages skip. There are no published, peer-reviewed human clinical trial results for 5 Amino 1MQ. Searches for 5 amino 1mq human trials surface a great deal of marketing prose and no trial reports, because the compound has not completed a registered clinical trial. It carries no FDA approval for any indication, in any population, at any quantity. Rodent adipose data is a hypothesis generator, not evidence of a human effect, and the distance between those two things is where most writing on this compound goes wrong.

Everything here is laboratory documentation. 5 Amino 1MQ is supplied for in vitro and laboratory research use only and is not for human or veterinary consumption. If curiosity about this compound started with an animal's health, talk to your veterinarian about that, because a research catalog is not the place for it.

Hedged claims should stay hedged. Research suggests NNMT inhibition alters adipocyte energy handling in rodent models. That is the honest ceiling on the current claim, and our team states it that way every time a customer asks.

Reading a 5 amino 1mq certificate of analysis line by line

A certificate of analysis is a batch document, not a product document. It describes one lot, tested on one date, and it's only useful if the lot number printed on it matches the lot number on the vial in your hand. That cross-check fails more often than anyone admits, and a mismatched 5-amino-1mq coa is functionally a blank page.

A complete 5-amino-1mq certificate of analysis contains:

• Lot or batch number and date of analysis, matching the container label exactly
• Identity by mass spectrometry, confirming the expected molecular ion for the 5-amino-1-methylquinolinium cation
• Structural confirmation by NMR, proton and ideally carbon, showing the methyl and amino substitution pattern
• Purity by HPLC, with column, mobile phase, gradient and detection wavelength stated
• Water content by Karl Fischer titration, since hygroscopic salts carry water that inflates apparent mass
• Residual solvents by GC and elemental impurities by ICP-MS
• Appearance, storage conditions, and the laboratory or analyst who signed it

So what does a purity number actually prove? Less than you'd think. HPLC purity is reported as area percent: the share of total UV absorbance the detector saw at one wavelength that belongs to your peak. Anything that doesn't absorb at that wavelength is invisible to it. Inorganic salts, residual water and non-chromophoric residues never appear. A 99% area-percent figure with no mass spectrum, no NMR and no Karl Fischer value is a statement about one detector's field of view, not about the contents of the vial. Purity without identity is the single most common documentation gap we see, and it's why our published certificates of analysis are lot-matched and posted alongside each listing, including 5-Amino-1MQ.

Documentation tiers and what each one actually proves

Not every certificate carries the same evidentiary weight, and the difference matters when an unexplained result forces you to rule out the material itself. This table maps what each documentation tier verifies, what it leaves open, and whether it's defensible for laboratory work.

What If: Verification Scenarios in the Lab

What if my 5 amino 1mq certificate lists purity but no mass spectrum?

Request the mass spectrometry data for that lot before the material enters any experiment. Without a confirmed molecular ion, you have a clean chromatogram of an unidentified substance, which is a different problem from an impure one. Suppliers who run identity testing keep those files on hand and can produce them within a day; suppliers who can't produce them generally never ran the analysis.

What if the lot number on the vial doesn't match the certificate?

Stop and contact the supplier before opening the container. A certificate describes one synthesis batch tested on one date, so a mismatch means the document in front of you describes different material entirely. This is the most common documentation failure our team encounters, and it's usually a fulfilment error rather than fraud, but the fix is the same: get the correct lot-matched test report reissued.

What if the powder looks different from the appearance stated on the report?

Photograph it, don't use it, and raise it with the supplier. Quinolinium iodide salts can darken with light exposure, and hygroscopic material can clump after humidity ingress during transit, so a deviation from the stated appearance is a real signal about handling history rather than a cosmetic quibble. Neither change is detectable by purity testing you can perform at the bench.

What if my results don't replicate a published rodent finding?

Rule out the material before rethinking the hypothesis. Differences in salt form, water content and actual mass of active cation shift effective concentration substantially, and a batch carrying several percent water by Karl Fischer delivers less compound per weighed milligram than the label implies. Check the certificate values first, then vehicle, then model.

The unglamorous truth about purity claims on research compounds

Here's the honest answer: most purity numbers advertised for this compound are copied, not measured. A number printed in a product description with no accompanying chromatogram, no lot reference and no analysing laboratory carries zero evidentiary value, and it appears identically across dozens of unrelated sites because it was never generated by anyone selling it. The evidence is clear on what fixes this. Demand the raw instrument output, matched to the lot in your hand, from a laboratory that doesn't share ownership with the seller. Everything else is decoration. Our full research catalog is documented on that standard for exactly this reason.

5 Amino 1MQ occupies an awkward and honest position: a genuinely interesting enzymology target with a real preclinical literature behind it, and almost nothing else. The temptation across this corner of the market is to fill that gap with confident language about metabolic outcomes nobody has measured in people. Resisting that is what separates research documentation from sales copy. If you take one habit away from this, make it the lot-number cross-check, because a compound you can't identify produces data you can't defend, no matter how clean the chromatogram looks.